for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Mallinckrodt Announces Positive Findings In Inomax Gas

May 4 (Reuters) - Mallinckrodt Plc:

* MALLINCKRODT ANNOUNCES POSITIVE FINDINGS IN INOMAX® (NITRIC OXIDE) GAS, FOR INHALATION PHASE 4 OBSERVATIONAL REGISTRY IN NEONATES WITH PULMONARY HYPERTENSION; ENDS TRIAL EARLY

* MALLINCKRODT PLC - ENDED PHASE 4 OBSERVATIONAL REGISTRY EARLY DUE TO ACHIEVEMENT OF PRE-SPECIFIED PRIMARY OUTCOME MEASURE, NON-INFERIORITY

* MALLINCKRODT PLC - NO DRUG-RELATED SERIOUS ADVERSE EVENTS WERE ATTRIBUTED TO STUDY DRUG

* MALLINCKRODT PLC - DUE TO SERIOUSNESS OF CONDITION, A RANDOMIZED CONTROLLED TRIAL CANNOT BE CONDUCTED IN THE PRE-TERM NEONATE POPULATION Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up